Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,164.98
1,180.77
1,135.35
1,024.78
942.91
793.83
700.88
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,164.98
1,180.77
1,135.35
1,024.78
942.91
793.83
700.88
Raw Material Cost
773.27
790.67
792.49
654.54
545.53
540.42
486.68
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
292.88
281.11
265.74
185.43
165.99
159.28
117.13
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
52.66
63.39
59.55
13.87
9.85
10.61
10.89
Selling and Distribution Expenses
158.79
171.18
131.89
96.17
112.62
95.65
88.35
Other Expenses
-33.44
-33.30
-31.47
-18.61
-16.17
-15.72
-11.68
Total Expenditure (Excl Depreciation)
943.23
973.38
935.00
763.89
672.32
648.73
586.24
Operating Profit (PBDIT) excl Other Income
221.70000000000002
207.39999999999998
200.3
260.9
270.59999999999997
145.1
114.60000000000001
Other Income
11.54
24.70
18.72
10.76
20.48
3.12
4.63
Operating Profit (PBDIT)
325.85
322.58
323.66
372.82
354.48
200.94
170.88
Interest
52.66
63.39
59.55
13.87
9.85
10.61
10.89
Exceptional Items
-1.46
1.79
-46.36
-27.94
3.62
-14.38
1.32
Gross Profit (PBDT)
391.71
390.10
342.86
370.23
397.38
253.41
214.20
Depreciation
92.56
90.50
104.59
101.18
55.60
49.17
50.12
Profit Before Tax
179.17
170.49
113.16
229.84
292.65
126.79
111.18
Tax
52.16
60.27
45.46
83.68
84.07
39.36
32.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
132.41
113.79
62.37
134.24
209.58
85.83
77.20
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
132.41
113.79
62.37
134.24
209.58
85.83
77.20
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.06
-2.05
-1.83
-1.62
-0.68
0.10
0.62
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
131.35
111.74
60.53
132.62
208.90
85.93
77.81
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
694.38
604.42
539.21
531.59
497.32
321.97
278.65
Earnings per share (EPS)
2.46
2.11
1.16
2.49
3.89
1.59
1.43
Diluted Earnings per share
2.46
2.11
1.16
2.49
3.89
1.59
1.43
Operating Profit Margin (Excl OI)
19.03%
17.56%
17.65%
25.46%
29.53%
18.73%
16.57%
Gross Profit Margin
23.32%
22.1%
19.18%
32.3%
36.93%
22.17%
23.01%
PAT Margin
11.37%
9.64%
5.49%
13.1%
22.23%
10.81%
11.01%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -1.34% vs 4.00% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 17.64% vs 84.63% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 5.51% vs -2.30% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -16.88% vs 6.55% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Dermapharm Holding SE With
Figures in Million
Consolidate Annual Results
Change(EUR)
Change(%)
Net Sales
1,164.98
788.37
376.61
47.77%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,164.98
788.37
376.61
47.77%
Raw Material Cost
773.27
723.14
50.13
6.93%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
292.88
456.54
-163.66
-35.85%
Power Cost
0
0
0.00
Manufacturing Expenses
52.66
14.44
38.22
264.68%
Selling and Distribution Expenses
158.79
128.73
30.06
23.35%
Other Expenses
-33.44
-39.36
5.92
15.04%
Total Expenditure (Excl Depreciation)
943.23
929.25
13.98
1.50%
Operating Profit (PBDIT) excl Other Income
221.75
-140.87
362.62
257.41%
Other Income
11.54
29.33
-17.79
-60.65%
Operating Profit (PBDIT)
325.85
-12.07
337.92
2,799.67%
Interest
52.66
14.44
38.22
264.68%
Exceptional Items
-1.46
-1.31
-0.15
-11.45%
Gross Profit (PBDT)
391.71
65.24
326.47
500.41%
Depreciation
92.56
99.48
-6.92
-6.96%
Profit Before Tax
179.17
-127.30
306.47
240.75%
Tax
52.16
-24.86
77.02
309.81%
Provisions and contingencies
0
0
0.00
Profit After Tax
132.41
-103.52
235.93
227.91%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
132.41
-103.52
235.93
227.91%
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.06
0.00
-1.06
Other related items
0.00
0.00
0.00
Consolidated Net Profit
131.35
-103.52
234.87
226.88%
Equity Capital
0
0
0.00
Face Value
1.00
1.00
0.00
Reserves
694.38
813.70
-119.32
-14.66%
Earnings per share (EPS)
2.46
-0.58
3.04
524.14%
Diluted Earnings per share
2.46
-0.58
3.04
524.14%
Operating Profit Margin (Excl OI)
19.03%
-17.87%
0.00
36.90%
Gross Profit Margin
23.32%
-3.53%
0.00
26.85%
PAT Margin
11.37%
-13.13%
0.00
24.50%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 116.50 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -1.34% vs 4.00% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 13.14 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 17.64% vs 84.63% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 31.43 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 5.51% vs -2.30% in Dec 2024
Annual - Interest
Interest 5.27 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -16.88% vs 6.55% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.03%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






